The present invention identifies the global changes in gene expression associated
with liver cancer by examining gene expression in tissue from normal liver, metastatic
malignant liver and hepatocellular carcinoma. The present invention also identifies
expression profiles which serve as useful diagnostic markers as well as markers
that can be used to monitor disease states, disease progression, drug toxicity,
drug efficacy and drug metabolism.